SARS-CoV-2

The Latest

  • New Coronavirus Variant Surfaces In South Africa
    Coronavirus
    The new variant reportedly exhibits many of the same hallmarks as other variants, including increased transmissibility.
  • WHO Researchers Debunk Lab-Related COVID-19 Theories
    masks are essential
    It was "extremely unlikely" that the virus leaked from a Chinese-run lab, WHO investigators said.
  • Study Affirms COVID-19 Is Most Contagious In First 5 Days
    COVID-19 in South Korea
    A new study finds COVID-19 is at its most dangerous during the first five days after symptoms appear.
  • Study Warns Of Greater COVID-19 Infection Risk Among Households
    SARS-CoV-2
    A study indicates transmission of SARS-CoV-2 among household members is frequent from either children or adults.
  • COVID-19 Can Contaminate Banknotes, Touchscreens for Two Weeks
    SARS-CoV-2 virus
    The study showed the survival of the virus fell to less than a day at 40 C on some surfaces.
  • Previous Infection Might Lessen COVID-19 Severity
    SARS-CoV-2
    Centers for Disease Control and Prevention says most people become infected by one or more of these coronaviruses in the course of their lives.
  • Micromolecule Could Be Silver Bullet Against COVID-19, U.S. Scientists Say
    SARS-CoV-2
    University researchers hope Ab8 might be effective against COVID-19 and in protecting those who have never had the infection but aren’t immune.
  • WHO Says COVID-19 Is Getting Harder To Beat
    Covid-19
    "This is not an easy virus, and not an easy virus, either, to detect. It's not an easy virus to stop," a top WHO official said.
  • First Human Trial Finds Made-in-China COVID-19 Vaccine Is Safe
    A foreign journalist gets tested for the coronavirus disease (COVID-19) before attending a news conference
    A COVID-19 vaccine developed by a Chinese company based in Tianjin is the first in the world to exit a Phase I clinical trial and the first to enter Phase II.
  • Abbott Study Shows Almost Perfect Results Of COVID-19 Test
    HIGH ACCURACY
    Abbott Lab's trials have earned the nod of the Food and Drug Administration for emergency use
1   2